Monday, April 19, 2021 3:08:09 PM
There is another 20 million of warrants outstanding that are also at $11.50 that may be involved in some way that I do not understand at the moment. But the key point is that the holders of these warrants can also buy new shares at $11.50, so if they are part of the short interest, they cannot be squeezed. So there is a possibility that there is no real net short interest at all.
Not going to investigate further, however, because I have no interest in this company. Huge stock volume transactions and gigantic options volumes today. Sheep getting fleeced. A lot of foolishness once again.
Please remember that you have to subtract convertible debt, convertible preferred, and warrants from short interest, because most of these holders have already sold short the shares they are entitled to convert into -- they did it at the time they bought the convertible debt or preferred, for example, if it made sense at the time (it almost always does). Warrant holders do it all the time if the stock goes over their conversion price, which happened here. They don't have to convert the warrant by the way, if the stock again goes lower -- they can just buy lower and cover (as may be going on here) and hold on to the warrant in case it becomes more valuable in the future. They can keep doing this over and over, using the warrant as a baseline to work against. Short when its high, then cover when the stock is low, or cover with warrant if the stock never goes lower again.
Recent CLOV News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:07:27 PM
- Clover Health Reports Strong First Quarter 2024 Financial Results; Improves Guidance to Target Full-Year 2024 Adjusted EBITDA Profitability • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Clover Health to Participate at Bank of America 2024 Healthcare Conference and Present at 2024 Leerink Partners Healthcare Crossroads Conference • GlobeNewswire Inc. • 05/01/2024 08:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/30/2024 08:15:00 PM
- Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 04/23/2024 08:05:00 PM
- Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer • GlobeNewswire Inc. • 04/22/2024 08:05:00 PM
- Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions • GlobeNewswire Inc. • 04/04/2024 08:30:00 PM
- Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading • IH Market News • 03/12/2024 11:22:57 AM
- Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/16/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 09:41:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 08:51:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 09:10:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:21:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:31:57 PM
- Clover Health Provides Business Update and Full-Year 2024 Objectives • GlobeNewswire Inc. • 01/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:05:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:02:24 PM
- PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent • GlobeNewswire Inc. • 01/08/2024 10:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:30:34 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM